Harshit Shah

873 total citations
27 papers, 341 citations indexed

About

Harshit Shah is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harshit Shah has authored 27 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harshit Shah's work include Cancer, Lipids, and Metabolism (4 papers), Inflammatory mediators and NSAID effects (4 papers) and COVID-19 Clinical Research Studies (3 papers). Harshit Shah is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Inflammatory mediators and NSAID effects (4 papers) and COVID-19 Clinical Research Studies (3 papers). Harshit Shah collaborates with scholars based in United States, Germany and India. Harshit Shah's co-authors include Steven Y. Qian, Shruti Rawal, Lizhi Pang, Rangachari Balamurugan, Dan Shu, Hongzhi Wang, Venkatachalem Sathish, Danny Jonigk, Yi Xu and Mark Kuehnel and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer Research and The FASEB Journal.

In The Last Decade

Harshit Shah

25 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harshit Shah United States 11 114 54 36 36 33 27 341
Pan Cheng China 14 136 1.2× 31 0.6× 54 1.5× 49 1.4× 71 2.2× 38 638
Pengbo Wen China 12 251 2.2× 52 1.0× 45 1.3× 39 1.1× 13 0.4× 24 517
Wenbin Xu China 10 113 1.0× 24 0.4× 31 0.9× 45 1.3× 13 0.4× 19 316
Katharina R. Beck Switzerland 15 185 1.6× 45 0.8× 41 1.1× 48 1.3× 126 3.8× 22 539
Chen Xuan China 11 201 1.8× 24 0.4× 29 0.8× 61 1.7× 16 0.5× 42 426
Yanan Lu China 12 119 1.0× 44 0.8× 31 0.9× 50 1.4× 8 0.2× 42 412
Jinsha Liu China 12 326 2.9× 41 0.8× 36 1.0× 48 1.3× 23 0.7× 27 611
Yan‐Wei Xiang China 13 201 1.8× 51 0.9× 143 4.0× 55 1.5× 22 0.7× 26 577
Yali Zhang China 11 243 2.1× 21 0.4× 19 0.5× 29 0.8× 27 0.8× 22 493

Countries citing papers authored by Harshit Shah

Since Specialization
Citations

This map shows the geographic impact of Harshit Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harshit Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harshit Shah more than expected).

Fields of papers citing papers by Harshit Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harshit Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harshit Shah. The network helps show where Harshit Shah may publish in the future.

Co-authorship network of co-authors of Harshit Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Harshit Shah. A scholar is included among the top collaborators of Harshit Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harshit Shah. Harshit Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Harshit, et al.. (2023). Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death. Frontiers in Oncology. 13. 999738–999738. 2 indexed citations
2.
Werlein, Christopher, Maximilian Ackermann, Harshit Shah, et al.. (2022). INFLAMMATION AND VASCULAR REMODELING IN COVID-19 HEARTS. Journal of the American College of Cardiology. 79(9). 1823–1823. 2 indexed citations
3.
Shah, Harshit, et al.. (2022). Guduchi Ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-and-after study. European Journal of Integrative Medicine. 53. 102131–102131. 8 indexed citations
4.
Schubert, Stephanie, Christopher Werlein, Helge Stark, et al.. (2021). The Challenge of Long-Term Cultivation of Human Precision-Cut Lung Slices. American Journal Of Pathology. 192(2). 239–253. 25 indexed citations
5.
Dahl, Vedrana Andersen, Anders Bjorholm Dahl, Maximilian Ackermann, et al.. (2021). 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography. eLife. 10. 30 indexed citations
6.
Pang, Lizhi, Harshit Shah, Yi Xu, & Steven Y. Qian. (2021). Delta-5-desaturase: A novel therapeutic target for cancer management. Translational Oncology. 14(11). 101207–101207. 9 indexed citations
7.
Vijayan, Vijith, Elena Korenbaum, Harshit Shah, et al.. (2021). Alpha1-antitrypsin counteracts heme-induced endothelial cell inflammatory activation, autophagy dysfunction and death. Redox Biology. 46. 102060–102060. 10 indexed citations
8.
Pang, Lizhi, Harshit Shah, Steven Y. Qian, & Venkatachalem Sathish. (2021). Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer. Free Radical Biology and Medicine. 172. 167–180. 5 indexed citations
9.
10.
Lu, Cuifen, Wan Xu, Harshit Shah, et al.. (2020). In Vitro Photodynamic Therapy of Mononuclear and Dinuclear Iridium(III) Bis(terpyridine) Complexes. ACS Applied Bio Materials. 3(10). 6865–6875. 22 indexed citations
11.
Shah, Harshit, Lizhi Pang, Hongzhi Wang, et al.. (2020). Growth inhibitory and anti-metastatic activity of epithelial cell adhesion molecule targeted three-way junctional delta-5-desaturase siRNA nanoparticle for breast cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 30. 102298–102298. 10 indexed citations
12.
Shah, Harshit, Lizhi Pang, Steven Y. Qian, Pinjing Zhao, & Venkatachalem Sathish. (2020). Development of a Novel ω‐6 Polyunsaturated Fatty Acid Based Treatment Strategy for Non‐Melanoma Skin Cancer by Inhibiting Delta‐5‐Desaturase. The FASEB Journal. 34(S1). 1–1.
13.
Pang, Lizhi, Harshit Shah, Pinjing Zhao, Steven Y. Qian, & Venkatachalem Sathish. (2020). New Delta‐5‐Desaturase Inhibitor Suppress Lung Cancer Progression: A Paradigm Shift on COX‐2 Biology in Lung Cancer Treatment. The FASEB Journal. 34(S1). 1–1. 1 indexed citations
14.
Pang, Lizhi, Harshit Shah, Hongzhi Wang, et al.. (2020). EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation. Molecular Therapy — Nucleic Acids. 22. 222–235. 22 indexed citations
15.
Shah, Harshit, et al.. (2020). Large Vessel Strokes: Is Bridging With Intravenous Thrombolysis Still Beneficial in the Era of Endovascular Treatment?. Journal of Neurology Research. 10(5). 147–149. 1 indexed citations
16.
Ackermann, Maximilian, Helge Stark, Lavinia Neubert, et al.. (2019). Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. European Respiratory Journal. 55(3). 1900933–1900933. 41 indexed citations
17.
Xu, Yi, Lizhi Pang, Hongzhi Wang, et al.. (2018). Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression. Redox Biology. 21. 101085–101085. 35 indexed citations
18.
Haas, Michael J., et al.. (2017). High-Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-I Synthesis. Assay and Drug Development Technologies. 15(8). 362–371. 5 indexed citations
19.
Balamurugan, Rangachari, et al.. (2012). Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2(2). S941–S946. 41 indexed citations
20.
Shah, Harshit, Robert M. Conway, K.R. Van Quill, et al.. (2007). Beta-lapachone inhibits proliferation and induces apoptosis in retinoblastoma cell lines. Eye. 22(3). 454–460. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pan Cheng Breakdown of academic impact, for papers by Pengbo Wen Breakdown of academic impact, for papers by Wenbin Xu Breakdown of academic impact, for papers by Katharina R. Beck Breakdown of academic impact, for papers by Chen Xuan Breakdown of academic impact, for papers by Yanan Lu Breakdown of academic impact, for papers by Jinsha Liu Breakdown of academic impact, for papers by Yan‐Wei Xiang Breakdown of academic impact, for papers by Yali Zhang
Rankless by CCL
2026